Oxidative and nitrosative stress in pediatric pulmonary hypertension: Roles of endothelin-1 and nitric oxide

Vascular Pharmacology

Volumn 45, Issue 5, 2006, Pages 308-316

  Black, Stephen M ^a   Fineman, Jeffrey R ^b,c  

^a UNIVERSITY OF MONTANA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell signaling; Gene expression; Nitrosylation; Pulmonary hypertension; Reactive oxygen species

Indexed keywords

CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; HYDROGEN PEROXIDE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ARTICLE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOTHELIAL DYSFUNCTION; GENE EXPRESSION; HUMAN; LUNG VASCULAR RESISTANCE; MITOCHONDRIAL RESPIRATION; NITROSYLATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ADMINISTRATION, INHALATION; ANIMALS; CHILD; CHILD, PRESCHOOL; CYCLIC GMP; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFANT, NEWBORN; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSATION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; VASCULAR RESISTANCE;

EID: 33751086463     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2006.08.005     Document Type: Article

References (125)

1. Adnot S., Raffestin B., Eddahibi S., Braquet P., and Chabrier P.-E. Loss of endothelium-dependent relaxant activity in the pulmonary circulation of rats exposed to chronic hypoxia. J. Clin. Invest. 87 (1991) 155-162
2. Arai H., Hori S., Aramori I., Ohkubo H., and Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348 (1990) 730-732
3. Asikainen T.M., Raivio K.O., Saksela M., and Kinnula V.L. Expression and developmental profile of antioxidant enzymes in human lung and liver. Am. J. Respir. Cell Mol. Biol. 19 (1998) 942-949
4. Atz A., Adatia I., and Wessel D. Rebound pulmonary hypertension after inhalation of nitric oxide. Ann. Thorac. Surg. 62 (1996) 1759-1764
5. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 75 (1995) 725-748
6. Black S.M., Johengen M.J., and Soifer S.J. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr. Res. 44 (1998) 821-830
7. Black S.M., Heidersbach R.S., McMullan D.M., Bekker J.M., Johengen M.J., and Fineman J.R. Inhaled nitric oxide inhibits NOS activity in lambs: potential mechanism for rebound pulmonary hypertension. Am. J. Physiol. 277 (1999) H1849-H1856
8. Boulanger C., and Luscher T.F. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85 (1990) 587-590
9. Bradley L.M., Czaja J.F., and Goldstein R.E. Circulatory effects of endothelin in newborn piglets. Am. J. Physiol. 259 (1990) H1613-H1617
10. Brashers V.L., Peach M.J., and Rose Jr. C.E. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J. Clin. Invest. 82 (1988) 1495-1502
11. Brennan L.A., Wedgwood S., Bekker J.M., and Black S.M. The overexpression of copper-zinc superoxide dismutase protects NOS III from nitric oxide-mediated inhibition. DNA Cell Biol. 21 (2002) 827-838
12. Brennan L.A., Wedgwood S., and Black S.M. The overexpression catalase reduces NO-mediated inhibition of endothelial NO synthase. IUBMB Life 54 (2002) 261-265
13. Brennan L.A., Steinhorn R.H., Wedgwood S., Mata-Greenwood E., Roark E.A., Russell J.A., and Black S.M. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ. Res. 92 (2003) 683-691
14. ras and leads to the inhibition of endothelial NO synthase by protein nitration. DNA Cell Biol. 22 (2003) 317-328
15. Brown M., Miller F., Li W., Ellingson A., Mozena J., Chatterjee P., Engelhardt J., Zwacka R., Oberley L., Fang X., Spector A., and Weintraub N. Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells. Circ. Res. 85 (1999) 524-533
16. Cai H., and Harrison D. Endothelial dysfunction in cardiovascular disease: the role of oxidant stress. Circ. Res. 87 (2000) 840-844
17. Cai H., Griendling K.K., and Harrison D.G. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 24 (2003) 471-478
18. Cassin S., Kristova V., Davis T., Kadowitz P., and Gause G. Tone-dependent responses to endothelin in isolated perfused fetal sheep pulmonary circulation in situ. J. Appl. Physiol. 70 (1991) 1228-1234
19. Celermajer D.S., Cullen S., and Deanfield J.E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 87 (1993) 440-446
20. Cheng T.H., Shih N.L., Chen S.Y., Loh S.H., Cheng P.Y., Tsai C.S., Liu S.H., Wang D.L., and Chen J.J. Reactive oxygen species mediate cyclic strain-induced endothelin-1 gene expression via Ras/Raf/extracellular signal-regulated kinase pathway in endothelial cells. J. Mol. Cell. Cardiol. 33 (2001) 1805-1814
21. Christman B.W., McPherson C.D., Newman J.H., King G.A., Bernard G.R., Groves B.M., and Loyd J.E. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N. Engl. J. Med. 327 (1992) 70-75
22. Clerch L.B., and Massaro D. Oxidation-reduction-sensitive binding of lung protein to rat catalase mRNA. J. Biol. Chem. 267 (1992) 2853-2855
23. Clerch L.B., and Massaro D. Rat lung antioxidant enzymes: differences in perinatal gene expression and regulation. Am. J. Physiol. 263 (1992) L466-L470
24. Colavitti R., Pani G., Bedogni B., Anzevino R., Borrello S., Waltenberger J., and Galeotti T. Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277 (2002) 3101-3108
25. Cueto E., Lopez-Herce J., Sanchez A., and Carrillo A. Life-threatening effects of discontinuing inhaled nitric oxide in children. Acta Pediatr. 86 (1997) 1337-1339
26. Day R.W., Allen E.M., and Witte M.K. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest 112 (1997) 1324-1331
27. Dellinger R.P., Zimmerman J.L., Taylor R.W., Straube R.C., Hauser D.L., Criner G.J., Davis Jr. K., Hyers T.M., and Papadakos P. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit. Care Med. 26 (1998) 15-23
28. Dinh Xuan A.T., Higenbottam T.W., Clelland C., Pepke-Zaba J., Cremona G., and Wallwork J. Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br. J. Pharmacol. 99 (1990) 9-10
29. Dobyns E.L., Cornfield D.N., Anas N.G., Fortenberry J.D., Tasker R.C., Lynch A., Liu P., Eells P.L., Griebel J., Baier M., Kinsella J.P., and Abman S.H. Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J. Pediatr. 134 (1999) 406-412
30. Drummond G., Cai H., Davis M., Ramasamy S., and Harrison D. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ. Res. 86 (2000) 347-354
31. Erwin P.A., Lin A.J., Golan D.E., and Michel T. Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J. Biol. Chem. 280 (2005) 19888-19894
32. Fagan K.A., McMurtry I.F., and Rodman D.M. Role of endothelin-1 in lung disease. Respir. Res. 2 (2001) 90-101
33. Fineman J.R., Soifer S.J., and Heymann M.A. Regulation of pulmonary vascular tone in the perinatal period. Annu. Rev. Physiol. 57 (1995) 115-134
34. 2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr. Res. 18 (1984) 240-244
35. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., and Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem. Biophys. Res. Commun. 199 (1994) 1461-1465
36. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83 (1989) 1774-1777
37. Giaid A., and Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 333 (1995) 214-221
38. Giaid A., Yanagisawa M., Langleben D., Michel R.P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W.P., and Stewart D.J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328 (1993) 1732-1739
39. Griendling K.K., and FitzGerald G.A. Oxidative stress and cardiovascular injury: Part I. Basic mechanisms and in vivo monitoring of ROS. Circulation 108 (2003) 1912-1916
40. Griendling K.K., Sorescu D., Lassegue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2175-2183
41. Hislop A.A., Zhao Y.D., Springall D.R., Polak J.M., and Haworth S.G. Postnatal changes in endothelin-1 binding in porcine pulmonary vessels and airways. Am. J. Respir. Cell Mol. Biol. 12 (1995) 557-566
42. Huribal M., Kumar R., Cunningham M., Sumpio B., and McMillen M. Endothelin-stimulated monocyte supernatants enhance neutrophil superoxide production. Shock 1 (1994) 184-187
43. Ignarro L.J., Harbison R.G., Wood K.S., and Kadowitz P.J. Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J. Pharmacol. Exp. Ther. 237 (1986) 893-900
44. Imai T., Hirata Y., Emori T., Yanagisawa M., Masaki T., and Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 19 (1992) 753-757
45. Irukayama-Tomobe Y., Sakai S., and Miyauchi T. Chronic treatment with probucol effectively inhibits progression of pulmonary hypertension in rats. Life Sci. 67 (2000) 2017-2023
46. Ivy D.D., Kinsella J.P., and Abman S.H. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J. Clin. Invest. 93 (1994) 2141-2148
47. Ivy D.D., le Cras T.D., Parker T.A., Zenge J.P., Jakkula M., Markham N.E., Kinsella J.P., and Abman S.H. Developmental changes in endothelin expression and activity in the ovine fetal lung. Am. J. Physiol., Lung Cell Mol. Physiol. 278 (2000) L785-L793
48. Jenkinson P.C., Anderson D., and Gangolli S.D. Malformations induced in cultured rat embryos by enzymically generated active oxygen species. Teratog., Carcinog., Mutagen. 6 (1986) 547-554
49. Kamisaki Y., Saheki S., Nakane M., Palmieri J.A., Kuno T., Chang B.Y., Waldman S.A., and Murad F. Soluble guanylate cyclase from rat lung exists as a heterodimer. J. Biol. Chem. 261 (1986) 7236-7241
50. Kasemsri T., and Armstead W. Endothelin production links superoxide generation to altered opioid-induced pial artery vasodilation after brain injury in pigs. Stroke 28 (1997) 190-196
51. Katusic Z.S. Superoxide anion and endothelial regulation of arterial tone. Free Radic. Biol. Med. 20 (1996) 443-448
52. Kelly L.K., Wedgwood S., Steinhorn R.H., and Black S.M. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am. J. Physiol., Lung Cell. Mol. Physiol. 286 (2004) L984-L991
53. Kinsella J.P., Truog W.E., Walsh W.F., Goldberg R.N., Bancalari E., Mayock D.E., Redding G.J., deLemos R.A., Sardesai S., McCurnin D.C., Moreland S.G., Cutter G.R., and Abman S.H. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J. Pediatr. 131 (1997) 55-62
54. Kojima T., Hattori K., Hirata Y., Aoki T., Sasai-Takedatsu M., Kino M., and Kobayashi Y. Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: its possible correlation with bronchopulmonary dysplasia. Pediatr. Res. 39 (1996) 112-116
55. Kourembanas S., McQuillan L.P., Leung G.K., and Faller D.V. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92 (1993) 99-104
56. Kuchan M.J., and Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am. J. Physiol. 264 (1993) H150-H156
57. Kurihara H., Yoshizumi M., Sugiyama T., Takaku F., Yanagisawa M., Masaki T., Hamaoki M., Kato H., and Yazaki Y. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem. Biophys. Res. Commun. 159 (1989) 1435-1440
58. La M., and Reid J.J. Endothelin-1 and the regulation of vascular tone. Clin. Exp. Pharmacol. Physiol. 22 (1995) 315-323
59. Lamas S., Marsden P.A., Li G.K., Tempst P., and Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6348-6352
60. Lander H.M., Milbank A.J., Tauras J.M., Hajjar D.P., Hempstead B.L., Schwartz G.D., Kraemer R.T., Mirza U.A., Chait B.T., Burk S.C., and Quilliam L.A. Redox regulation of cell signalling. Nature 381 (1996) 380-381
61. Lander H.M., Hajjar D.P., Hempstead B.L., Mirza U.A., Chait B.T., Campbell S., and Quilliam L.A. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. J. Biol. Chem. 272 (1997) 4323-4326
62. Lavoie A., Hal l.J., Olson D., and Wylam M. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am. J. Respir. Crit. Care Med. 153 (1996) 1985-1987
63. Lopez Farre A., Riesco A., Moliz M., Egido J., Casado S., Hernando L., and Caramelo C. Inhibition by l-arginine of the endothelin-mediated increase in cytosolic calcium in human neutrophils. Biochem. Biophys. Res. Commun. 178 (1991) 884-891
64. Lopez-Ongil S., Senchak V., Saura M., Zaragoza C., Ames M., Ballermann B., Rodriguez-Puyol M., Rodriguez-Puyol D., and Lowenstein C.J. Superoxide regulation of endothelin-converting enzyme. J. Biol. Chem. 275 (2000) 26423-26427
65. Luscher T.F., Yang Z., Tschudi M., Von Segesser L., Stulz P., Boulanger C., Siebermann R., Turnia M., and Buhler F.R. Interaction between endothelin-1 and endothelium derived relaxing factor in human arteries and veins. Circ. Res. 66 (1990) 1088-1094
66. Lyons C.R., Orloff G.J., and Cunningham J.M. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 267 (1992) 6370-6374
67. Macarthur H., Warner T.D., Wood E.G., Corder R., and Vane J.R. Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch. Biochem. Biophys. Res. Commun. 200 (1994) 395-400
68. Marsden P.A., and Brenner B.M. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am. J. Physiol. 262 (1992) C854-C861
69. Matsubara T., and Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J. Immunol. 137 (1986) 3295-3298
70. Matsubara T., and Ziff M. Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J. Cell. Physiol. 127 (1986) 207-210
71. Matsuura A., Kawashima S., Yamochi W., Hirata K., Yamaguchi T., Emoto N., and Yokoyama M. Vascular endothelial growth factor increases endothelin-converting enzyme expression in vascular endothelial cells. Biochem. Biophys. Res. Commun. 235 (1997) 713-716
72. McElroy M.C., Postle A.D., and Kelly F.J. Catalase, superoxide dismutase and glutathione peroxidase activities of lung and liver during human development. Biochim. Biophys. Acta 1117 (1992) 153-158
73. McMullan D.M., Bekker J.M., Johengen M.J., Hendricks-Munoz K., Gerrets R., Black S.M., and Fineman J.R. Inhaled nitric oxide-induced rebound pulmonary hypertension: a role for endothelin-1. Am. J. Physiol. 280 (2001) H777-H785
74. Meyrick B., Gamble W., and Reid L. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am. J. Physiol. 239 (1980) H692-H702
75. Michelakis E.D., Tymchak W., Noga M., Webster L., Wu X.C., Lien D., Wang S.H., Modry D., and Archer S.L. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 108 (2003) 2066-2069
76. Miller O.I., Tang S.F., Keech A., and Celermajer D.S. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 346 (1995) 51-52
77. Minamino T., Kurihara H., Takahashi M., Shimada K., Maemura K., Oda H., Ishikawa T., Uchiyama T., Tanzawa K., and Yazaki Y. Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation 95 (1997) 221-230
78. Mitchell D.A., Erwin P.A., Michel T., and Marletta M.A. S-nitrosation and regulation of inducible nitric oxide synthase. Biochemistry (Mosc) 44 (2005) 4636-4647
79. Mitsutomi N., Akashi C., Odagiri J., and Matsumura Y. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur. J. Pharmacol. 364 (1999) 65-73
80. Morris C.R., Morris Jr. S.M., Hagar W., Van Warmerdam J., Claster S., Kepka-Lenhart D., Machado L., Kuypers F.A., and Vichinsky E.P. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?. Am. J. Respir. Crit. Care Med. 168 (2003) 63-69
81. Mott H.R., Carpenter J.W., and Campbell S.L. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation. Biochemistry (Mosc) 36 (1997) 3640-3644
82. Mulsch A., Bassenge E., and Busse R. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn-Schmiedebergs Arch. Pharmacol. 340 (1989) 767-770
83. Munzel T., Sayegh H., Freeman B.A., Tarpey M.M., and Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest. 95 (1995) 187-194
84. Murad F. Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78 (1986) 1-5
85. Okishio M., Ohkawa S., Ichimori Y., and Kondo K. Interaction between endothelium derived relaxing factors, nitrothiols and endothelin-1 on Ca2+ mobilization in rat vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 183 (1992) 849-855
86. Palmer R.M.J., Ashton D.S., and Moncada S. Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 333 (1988) 664-666
87. Pearl J.M., Nelson D.P., Raake J.L., Manning P.B., Schwartz S.M., Koons L., Shanley T.P., Wong H.R., and Duffy J.Y. Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension. Crit. Care Med. 30 (2002) 89-93
88. Pietarinen-Runtti P., Raivio K.O., Saksela M., Asikainen T.M., and Kinnula V.L. Antioxidant enzyme regulation and resistance to oxidants of human bronchial epithelial cells cultured under hyperoxic conditions. Am. J. Respir. Cell Mol. Biol. 19 (1998) 286-292
89. Rabinovitch M., Bothwell T., Hayakawa B.N., Williams W.G., Trusler G.A., Rowe R.D., Olley P.M., and Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. A correlation of light with scanning electron microscopy and transmission electron microscopy. Lab. Invest. 55 (1986) 632-653
90. Rao G., and Berk B. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 18 (1992) 775-794
91. Ravi K., Brennan L.A., Levic S., Ross P.A., and Black S.M. S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 2619-2624
92. Redmond E.M., Cahill P.A., Hodges R., Zhang S., and Sitzmann J.V. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells. J. Cell. Physiol. 166 (1996) 469-479
93. Rickett G.M., and Kelly F.J. Developmental expression of antioxidant enzymes in guinea pig lung and liver. Development 108 (1990) 331-336
94. Roberts J.D., Fineman J.R., Morin F.C.r., Shaul P.W., Rimar S., Schreiber M.D., Polin R.A., Zwass M.S., Zayek M.M., Gross I., Heymann M.A., and Zapol W. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group. N. Engl. J. Med. 336 (1997) 605-610
95. Ross R. A pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
96. Rossi G.P., Seccia T.M., and Nussdorfer G.G. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int. Rev. Cytol. 209 (2001) 241-272
97. Rubanyi G.M., Romero J.C., and Vanhoutte P.M. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250 (1986) H1145-H1149
98. Sakurai T., Yanagisawa M., Takuwa Y., Miyyazaki H., Kimura S., Goto K., and Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348 (1990) 732-735
99. Schreiber M.D., Gin-Mestan K., Marks J.D., Huo D., Lee G., and Srisuparp P. Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N. Engl. J. Med. 349 (2003) 2099-2107
100. Sessa W.C., Harrison J.K., Luthin D.R., Pollock J.S., and Lynch K.R. Genomic analysis and expression patterns reveal distinct genes for endothelial and brain nitric oxide synthase. Hypertension 21 (1993) 934-938
101. Sheehy A.M., Burson M.A., and Black S.M. Nitric oxide exposure inhibits endothelial NOS activity but not gene expression: a role for superoxide. Am. J. Physiol. 274 (1998) L833-L841
102. Shetty S.S., Okada T., Webb R.L., DelGrande D., and Lappe R.W. Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 191 (1993) 459-464
103. Shimada K., Matsushita Y., Wakabayashi K., Takahashi M., Matsubara A., Iijima Y., and Tanzawa K. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem. Biophys. Res. Commun. 207 (1995) 807-812
104. Smith A.P., Demoncheaux E.A., and Higenbottam T.W. Nitric oxide gas decreases endothelin-1 mRNA in cultured pulmonary artery endothelial cells. Nitric Oxide 6 (2002) 153-159
105. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., and Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347 (1996) 781-786
106. Stocker C., Penny D.J., Brizard C.P., Cochrane A.D., Soto R., and Shekerdemian L.S. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med. 29 (2003) 1996-2003
107. 2 for platelet-derived growth factor signal transduction. Science 270 (1995) 296-299
108. Teerlink J.R., Loffler B.M., Hess P., Maire J.P., Clozel M., and Clozel J.P. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure. Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan). Circulation 90 (1994) 2510-2518
109. Thomas S.R., Chen K., and Keaney Jr. J.F. Hydrogen peroxide activates endothelial nitric-oxide synthase through coordinated phosphorylation and dephosphorylation via a phosphoinositide 3-kinase-dependent signaling pathway. J. Biol. Chem. 277 (2002) 6017-6024
110. Tsai J., Jain M., Hsieh C., Lee W., Yoshizumi M., Patterson C., Perralla M., Cook C., Wang H., Haber E., Schlegal R., and Lee M. Induction of apoptosis by pyrrolidinedithiocarbamate and N-acetylcysteine in vascular smooth muscle cells. J. Biol. Chem. 271 (1996) 3667-3670
111. Vanhoutte P.M. Say NO to ET. J. Auton. Nerv. Syst. 81 (2000) 271-277
112. Watanabe H., Ohashi K., Takeuchi K., Yamashita K., Yokoyama T., Tran Q.K., Satoh H., Terada H., Ohashi H., and Hayashi H. Sildenafil for primary and secondary pulmonary hypertension. Clin. Pharmacol. Ther. 71 (2002) 398-402
113. Wedgwood S., and Black S.M. Molecular mechanisms of nitric oxide-induced growth arrest and apoptosis in fetal pulmonary arterial smooth muscle cells. Nitric Oxide 9 (2003) 201-210
114. Wedgwood S., and Black S.M. Role of reactive oxygen species in vascular remodeling associated with pulmonary hypertension. Antioxid. Redox Signal. 5 (2003) 759-769
115. Wedgwood S., and Black S.M. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am. J. Physiol., Lung Cell. Mol. Physiol. 288 (2005) L480-L487
116. Wedgwood S., Dettman R., and Black S.M. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am. J. Physiol., Lung Cell. Mol. Physiol. 281 (2001) L1058-L1067
117. Wedgwood S., McMullan D.M., Bekker J.M., Fineman J.R., and Black S.M. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ. Res. 89 (2001) 357-364
118. Wedgwood S., Steinhorn R.H., Bunderson M., Wilham J., Lakshminrusimha S., Brennan L.A., and Black S.M. Increased hydrogen peroxide down-regulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005) L660-L666
119. Wong J., Vanderford P.A., Fineman J.R., Chang R., and Soifer S.J. Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am. J. Physiol. 265 (1993) H1318-H1325
120. Wong J., Vanderford P.A., Fineman J.R., and Soifer S.J. Developmental effects of endothelin-1 on the pulmonary circulation in sheep. Pediatr. Res. 36 (1994) 394-401
121. Wong J., Vanderford P.A., Winters J., Soifer S.J., and Fineman J.R. Endothelin b receptor agonists produce pulmonary vasodilation in intact newborn lambs with pulmonary hypertension. J. Cardiovasc. Pharmacol. 25 (1995) 207-215
122. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 (1988) 411-415
123. Yoshibayashi M., Nishioka K., Nakao K., Saito Y., Matsumura M., Ueda T., Temma S., Shirakami G., Imura H., and Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84 (1991) 2280-2285
124. Yuan H.T., Bingle C.D., and Kelly F.J. Differential patterns of antioxidant enzyme mRNA expression in guinea pig lung and liver during development. Biochim. Biophys. Acta 1305 (1996) 163-171
125. Zou M.H., Shi C., and Cohen R.A. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J. Clin. Invest. 109 (2002) 817-826